Septicemia with Staphylococcus aureus, beta-hemolytic streptococci group B and G, and Escherichia coli in a patient with rheumatoid arthritis treated with a recombinant human interleukin 1 receptor antagonist (Anakinra).
Turesson
Carl
C
Riesbeck
Kristian
K
D000368:Aged; D018501:Antirheumatic Agents / Q000009:adverse effects*; D001172:Arthritis, Rheumatoid / Q000150:complications* / Q000188:drug therapy*; D004927:Escherichia coli Infections / Q000209:etiology; D005260:Female; D006801:Humans; D053590:Interleukin 1 Receptor Antagonist Protein; D018805:Sepsis / Q000209:etiology* / Q000382:microbiology; D012795:Sialoglycoproteins / Q000009:adverse effects*; D013290:Streptococcal Infections / Q000209:etiology; D013292:Streptococcus agalactiae
D018501:Antirheumatic Agents; C507763:IL1RN protein, human; D053590:Interleukin 1 Receptor Antagonist Protein; D012795:Sialoglycoproteins